Both in Pharmaceuticals
Vanda Pharmaceuticals vs Evommune
Over the past year VNDA returned +14.1% and EVMN returned −58.7%; their daily moves had a correlation of 0.05.
VNDA +14.1% EVMN −58.7%Growth of $1, one year, split-adjusted
| Metric | VNDA | EVMN |
|---|---|---|
| Price | $5.03 | $8.35 |
| Market cap | $304.1M | $303.0M |
| Today | −2.71% | −0.48% |
| 1 month | −4.9% | −36.9% |
| 6 months | −24.4% | −62.0% |
| Year to date | −43.0% | −51.2% |
| 1 year | −1.4% | — |
| Revenue growth (YoY) | −3.9% | — |
| Gross margin | 93.0% | — |
| Net margin | −123.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | — |
| Net cash | $166.9M | $200.4M |
| Dividend yield | — | — |
| Volatility (60d) | 39.6% | 74.5% |
| Short % of float | 15.7% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).